HBSP (USA)
-
MorphoSys AG: The Evolution of a Biotechnology Business Model
Pisano, Gary P.; Johnson, Ryan; Knoop, Carin-IsabelCase HBS-611046-EService and Operations ManagementIn the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this profitability not by developing and selling its own drugs, but by licensing access to its proprietary library of human antibodies. Recently, the company decided to deviate from this model, and attempt to develop its own proprietary products. The case allows analysis of "license vs. vertically integrate" business model de...Starting at €8.20
-
Hapag-Lloyd AG: Complying with IMO 2020
Esty, Benjamin C.; Moloney, Emer; Hjortshoej, Mette FuglsangCase HBS-220003-EFinanceA new environmental regulation known as IMO 2020 was creating what one industry analyst called "the biggest shakeup for the oil and shipping industries in decades." According to the new regulation, all ocean-going ships would have to limit their sulfur emissions by January 1, 2020. Senior leaders at Hapag-Lloyd, one of the world's largest shipping companies, were evaluating three ways their ships could comply with the new regulation: use low sulf...Starting at €8.20
-
Germany's Green Energy Revolution
Maurer, Noel; Corsi, Elena; Billaud, Emilie; Moloney, EmerCase HBS-713049-EEconomicsStarting at €8.20